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Abstract
We report the exceptional case of hepatocellular car-
cinoma in a non-cirrhotic patient, whose Wilson’s dis-
ease was diagnosed at the unusual age of 58 years. 
The liver histology revealed macrovesicular steatosis 
with fibrosis, but no cirrhosis. The disease was treated 
with D-penicillamine for 3 years until acute discomfort 
in the right upper quadrant led to detection of multifo-
cal hepatocellular carcinoma, which was successfully 
resected. The histological examination confirmed the 
malignant nature of the 4 lesions, which were clas-
sified according to Edmondson and Steiner as poorly 
differentiated hepatocellular carcinoma grade 3. The 
non-tumoral parenchyma showed 80% steatosis with 
ballooned cells, lobular inflammation, septal fibrosis 
but no cirrhosis. Hepatocellular carcinoma is rare in 
Wilson’s disease, especially in the absence of cirrhosis. 
The literature’s 28 published cases are reviewed and 
the contributory role of copper in the hepatocarcino-
genic process is discussed.
© 2013 Baishideng. All rights reserved.
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INTRODUCTION
Wilson’s disease is an autosomal recessive disorder of  
copper metabolism. Wilson’s disease has a worldwide 
prevalence between 1 in 30 000 and 1 in 100 000[1]. The 
responsible gene ATP7B is located on chromosome 13 
and encodes a copper transporter. In Wilson’s disease, 
the copper transporter is mutated and its function is im-
paired[1]. Wilson’s disease has hepatic, neurological, psy-
chiatric and ophthalmic manifestations. Hepatic manifes-
tations are characterized histologically by steatohepatitis, 
which evolves into cirrhosis if  left untreated. Because 
most cases of  Wilson’s disease are diagnosed and treated 
early, hepatocellular carcinoma is a rare sequela. We re-
port the unusual case of  a Wilson’s disease patient diag-
nosed at an advanced age and who developed hepatocel-
lular carcinoma in a non-cirrhotic liver.
CASE REPORT
The patient underwent cholecystectomy due to sympto-
matic gallstones at 51 years of  age. Liver biopsies showed 
macrovesicular steatosis. The circulating levels of  gam-
ma-glutamyltransferase remained chronically elevated 
and the ALT levels were at the upper limit of  the nor-
mal. A computed tomography (CT) scan performed 5 
years later revealed the presence of  a 3 cm subcapsular 
lesion in liver segment Ⅵ as well as several ≤ 1 cm le-
sions. All lesions displayed a discrete enhancement dur-
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ing the arterial phase without washout during the portal 
phase. Radiological controls over the next 2 years re-
vealed no evolution of  these lesions. The biopsy of  the 
largest lesion showed fibrotic remodelling corresponding 
to Metavir F3 or a modified Ishak score of  4 without 
evidence of  cirrhosis, a 25% macrovascular steatosis, 
a moderate chronic hepatic inflammation and an area 
with small cell dysplasia. A broad clinical examination 
was negative for neurological and ophthalmic (Kayser-
Fleischer-rings) signs of  Wilson’s disease. However ceru-
loplasmin levels below the limit of  detection (0.1 g/L) 
and urinary copper excretion was elevated. A genetic 
test confirmed a frameshift-mutation in exon 14 and 2 
missense-mutations in exons 18 and 21 of  the ATP7B 
gene. The patient was treated with D-penicillamine and 
pyridoxal-phosphate. This treatment was well tolerated. 
An magnetic resonance imaging with hepatocellular spe-
cific contrast confirmed the known lesions, which were 
stable in size and interpreted as regeneration nodules. 
The patient worked as a mechanic, never smoked and 
consumed less than 10 g alcohol per day. His mother 
had metastatic breast carcinoma and died of  a cerebral 
haemorrhage. His father suffered from an undefined 
psychiatric condition. His 2 brothers and 1 sister are in 
good health. He has no children.
At the age of  61 years, the patient presented with 
acute pain in the right upper quadrant, which was preced-
ed for several weeks by discomfort. Contrast-enhanced 
CT revealed 4 hepatic lesions showing enhancement 
during the arterial phase and washout during the portal 
phase. Two lesions of  3.7 cm and 2.1 cm were in seg-
ment Ⅳ, 1 lesion of  3.2 cm was in the segment V and 
the largest lesion of  9.7 cm was in segments Ⅵ and Ⅶ. 
A curative resection was performed. The histological 
examination confirmed the malignant nature of  the 4 le-
sions, which were classified according to Edmondson and 
Steiner as poorly differentiated hepatocellular carcinoma 
grade 3. The non-tumoral parenchyma showed 80% ste-
atosis with ballooned cells, lobular inflammation, septal 
fibrosis but no cirrhosis. Moreover, there was a mild iron 
hepatocellular accumulation (Rowe 1), which was absent 
on the previous biopsy.
DISCUSSION
All the published cases of  hepatocellular carcinoma oc-
curring in patients with Wilson’s disease are listed in Ta-
ble 1. As expected for hepatocellular carcinoma, males 
predominate whereas female constitute a lower than ex-
pected percentage (14%) of  this group. Females consti-
tute 30% of  overall hepatocellular carcinoma cases. The 
reason may be that cirrhosis initiated by Wilson’s disease 
Table 1  Synopsis of patients with hepatocellular carcinoma and Wilson’s disease
Ref. Sex WD-age 
(yr)
HCC-age 
(yr)
Cirrhosis Medical therapy Invasive therapy Status
Guan et al[2] Female 23 27 Yes Penicillamin Hepatic resection Alive
Iwadate et al[3] Male 17 23 Yes Penicillamin, low copper diet - Dead
Lowette et al[4] - - - Yes Penicillamin Transplant Alive
Ikegawa et al[5] Male 28 37 Yes Penicillamin, zinc acetate dehydrate Radiofrequency ablation Alive
Kumagi et al[6] Male 26 66 Yes Penicillamin, transplant Transcatheter arterial chemoembolisation Dead
Kumagi et al[6] Male 27 36 Yes Penicillamin, transplant - Dead
Kumagi et al[6] Male 27 46 Yes Penicillamin - Alive
Lygren et al[15] Male 15 16 Yes - - Dead
Girard et al[16] Male 22 41 Yes Penicillamin - Dead
Kamakura et al[17] Male 26 32 Yes Penicillamin - Dead
Terao et al[18] Male 29 40 Yes Penicillamin, dimercaprol potassium 
sulfate
- Dead
Wilkinson et al[19] Male 31 41 Yes Penicillamin - Dead
Buffet et al[20] Male 45 57 Yes Penicillamin - Dead
Imhof et al[21] Male 18 40 - Penicillamin Hepatic resection Alive
Madden et al[22] Male 61 61 Yes Penicillamin - Dead
Polio et al[23] Male 32 33 Yes Penicillamin, low copper diet Chemotherapy Dead
Cheng et al[24] Female 39 72 Yes Penicillamin, dimercaprol potassium 
sulfate
- Dead
Agret et al[25] Male 73 73 Yes - - Dead
Walshe et al[26] Male   8 46 Yes Penicillamin Transplant Alive
Walshe et al[26] Male 11 42 Yes Penicillamin - Dead
Kumagi et al[27] Male 66 66 Yes - Transcatheter arterial chemoembolisation Dead
Ozçay et al[28] Male - 13 Yes Penicillamin Transplant Alive
Aydinli et al[29] Male 22 22 Yes - Radiofrequency ablation, transplant Alive
Xu et al[30] Male 29 29 Yes - Transcatheter arterial chemoembolisation, 
transplant
Alive
Reyes et al[31] Male 59 59 Yes - - Dead
Emlakçioglu et al[32] Female 30 50 - Penicillamin Transcatheter arterial chemoembolisation Alive
Ikubo et al[33] Female 28 54 Yes Penicillamin, pyridoxal-phosphate Hepatic resection Alive
Savas et al[34] Male   6 12 Yes Penicillamin, low copper diet Transplant Alive
WD: Wilson’s disease; HCC: Hepatocellular carcinoma diagnosis.
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is less carcinogenic than that linked to other cirrhotic 
conditions and that male gender provides additional 
susceptibility to initiate hepatocarcinogenesis. Because 
it is uncertain from the information in previous reports 
whether other risk factors had been considered and ex-
cluded[2-6], it is not possible to fully assess whether com-
mon features could link them to the hepatocarcinogenic 
process in our male patient with longstanding, untreated 
Wilson’s disease. However, our patient was exceptional 
in that he was non-cirrhotic, whereas all previous cases 
of  hepatocellular carcinoma in Wilson’s disease occurred 
in cirrhotic livers (Table 1).
Long-Evans cinnamon rats, which have a mutated 
ATP7B gene and are therefore an experimental model 
for Wilson’s disease, develop hepatocellular carcinoma 
spontaneously. However, these animals accumulate iron 
in addition to copper, and an iron-deficient iron diet 
can abrogate the development of  liver tumors[7]. This 
was attributed to the role of  iron in promoting reactive 
oxygen species and DNA strand breaks[8]. Copper can 
assume a similar role. Mice receiving copper develop 
hepatocellular carcinoma, preventable by the concurrent 
administration of  thiamine, which reduces the produc-
tion of  reactive oxygen species in the mitochondria[9]. In 
addition, copper stabilizes hypoxia-inducible factor-1α 
(HIF-1α)[10-12] by restraining the activity of  the HIF-1α-
inhibition factor[10], thereby ensuring the formation of  
the HIF-1α transcriptional complex[11,12] and the expres-
sion of  target genes important for angiogenesis, such as 
vascular endothelial growth factor (VEGF)[10]. Indeed, 
Martin showed that copper increases VEGF in human 
hepatoma cells[12]. Another potential carcinogenic prop-
erty of  copper is its ability to stimulate fibroblast growth 
factor-2[13]. Treatment with D-penicillamine promotes 
hepatocellular iron accumulation[14]. It is possible that the 
D-penicillamine treatment of  our patient contributed to 
the oxidative stress through and increase in iron.
When our case is combined with the 28 published 
cases of  hepatocellular carcinoma (Table 1), the mean 
age at diagnosis of  Wilson’s disease was 31 ± 18 years: 
30 ± 7 years for women and 32 ± 19 years for men. The 
diagnosis of  this genetic disease at such an advanced age 
suggests that longstanding, untreated Wilson’s disease 
may represent a risk factor for hepatocellular carcinoma. 
This notion is supported by the observation that the 
mean age at diagnosis of  hepatocellular carcinoma was 
younger than that observed in patients with other under-
lying liver diseases (43 ± 18 years).
In conclusion, this case report illustrates that hepato-
cellular carcinoma does occur in patients with Wilson's 
disease and that those with longstanding, untreated dis-
ease may be particularly vulnerable. Therefore, the im-
portance of  determining the fibrosis stage of  Wilson's 
disease patients and of  enrolling them in a surveillance 
program when cirrhotic can only be emphasized.
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